首頁 › 急性淋巴母細胞性白血病 › 科羅拉多 › Aurora
Aurora, CO 的 急性淋巴母細胞性白血病 臨床試驗
8 項針對 急性淋巴母細胞性白血病 的研究正在 Aurora（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中觀察性研究
- Children's Hospital Colorado, Aurora
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
招募中1/2 期
- University of Colorado, Aurora
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
招募中1 期
- Children's Hospital Colorado, Aurora
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Children's Hospital Colorado, Aurora
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
Venetoclax Basket Trial for High Risk Hematologic Malignancies
招募中1 期
- Children's Hospital Colorado, Aurora
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
招募中1 期
- University of Colorado Hospital, Aurora
其他城市的 急性淋巴母細胞性白血病 試驗
- Houston, TX28 項研究
- New York City, NY24 項研究
- Baldwin Park, CA21 項研究
- Seattle, WA21 項研究
- Chicago, IL19 項研究
- Atlanta, GA19 項研究
- Philadelphia, PA16 項研究
- Memphis, TN16 項研究
- Washington, DC16 項研究
- Boston, MA15 項研究
- Los Angeles, CA14 項研究
- Durham, NC13 項研究
Aurora 的其他研究
- 癌症（所有類型）35 項研究
- 大腸直腸癌32 項研究
- 非小細胞肺癌30 項研究
- 乳癌27 項研究
- 轉移性癌症25 項研究
- 卵巢癌25 項研究
- 第一型糖尿病23 項研究
- 肥胖症21 項研究
- 肺癌19 項研究
- 前列腺癌19 項研究
- 心臟衰竭18 項研究
- 黑色素瘤18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。